New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Enanta Pharmaceuticals, Inc. (ENTA) vs Century Therapeutics, Inc. (IPSC)
- Enanta Pharmaceuticals, Inc. ENTA 7.62 −4.51%
- Century Therapeutics, Inc. IPSC 1.17 −11.36%
Enanta Pharmaceuticals, Inc. and Century Therapeutics, Inc. are both Biotechnology companies. Enanta Pharmaceuticals, Inc. and Century Therapeutics, Inc. are of similar size ($239.7M and $232.7M). Century Therapeutics, Inc. grew revenue faster over the last twelve months: 8,286.7% against −3.56%. Century Therapeutics, Inc. has the higher net margin (−19.1% vs −108.3%) and the lower return on invested capital (−71.5% vs 0.00%). Across the 15 metrics below, Century Therapeutics, Inc. leads on 8 and Enanta Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | ENTA | IPSC | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 70.18% |
| Operating margin | (99.01%) | (28.42%) | 0.00% |
| Net margin | (108.33%) | (19.10%) | 0.00% |
| Free cash flow margin | (67.88%) | (99.74%) | 0.00% |
| Return on equity | (94.19%) | (51.16%) | (51.58%) |
| Return on assets | (24.54%) | (38.96%) | (45.91%) |
| Return on invested capital | 0.00% | (71.47%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack